References
Tosaka M, Sato N, Hirato J, Fujimaki H, Yamaguchi R, Kohga H, Hashimoto K, Yamada M, Mori M, Saito N, Yoshimoto Y (2007) Assessment of hemorrhage in pituitary macroadenoma by T2*-weighted gradient-echo MR imaging. Am J Neuroradiol 28(10):2023–2029. doi:10.3174/ajnr.A0692
Bi WL, Dunn IF, Laws ER Jr (2014) Pituitary apoplexy. Endocrine. doi:10.1007/s12020-014-0359-y
Chatterjee S, Sardar P, Biondi-Zoccai G, Kumbhani DJ (2013) New oral anticoagulants and the risk of intracranial hemorrhage: traditional and Bayesian meta-analysis and mixed treatment comparison of randomized trials of new oral anticoagulants in atrial fibrillation. JAMA Neurol 70(12):1486–1490. doi:10.1001/jamaneurol.2013.4021
Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361(12):1139–1151. doi:10.1056/NEJMoa0905561
Uemura M, Miyashita F, Shimomura R, Fujinami J, Toyoda K (2013) Pituitary apoplexy during treatment with dabigatran. Neurol Clin Neurosci 1:82–83
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Doglietto, F., Costi, E., Villaret, A.B. et al. New oral anticoagulants and pituitary apoplexy. Pituitary 19, 232–234 (2016). https://doi.org/10.1007/s11102-014-0616-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11102-014-0616-3